Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.81 |
| ▸ | MEN1 | O00255 | 5/20 | 0.81 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | CKS1B | P61024 | 1/20 | 0.48 |
| ▸ | SKP1 | P63208 | 1/20 | 0.48 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.45 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4266360 | 0.87 | KMT2A (0.69) | KMT2AMEN1MAPTSMN1; SMN2TSHR | |
| SCHEMBL11612951 | 0.80 | KMT2A (0.60) | KMT2AMEN1MAPTSMN1; SMN2TSHR | |
| SCHEMBL11619536 | 0.79 | MEN1 (0.55) | KMT2AMEN1MAPTSMN1; SMN2TSHR | |
| SCHEMBL8296944 | 0.78 | KMT2A (0.58) | KMT2AMEN1MAPTSMN1; SMN2TSHR | |
| SCHEMBL11892570 | 0.77 | KMT2A (0.52) | KMT2AMEN1MAPTSMN1; SMN2TSHR | |
| SCHEMBL14274943 | 0.76 | MEN1 (0.55) | KMT2AMEN1MAPTSMN1; SMN2TSHR | |
| SCHEMBL23184017 | 0.74 | KMT2A (0.53) | KMT2AMEN1MAPTSMN1; SMN2TSHR | |
| SCHEMBL371042 | 0.72 | L3MBTL1 (0.74) | KMT2AMEN1MAPTSMN1; SMN2TSHR | |
| SCHEMBL11417489 | 0.71 | MEN1 (0.69) | KMT2AMEN1MAPTSMN1; SMN2USP2 | |
| SCHEMBL26027456 | 0.71 | KMT2A (0.50) | KMT2AMEN1MAPTSMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100127616-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2010-05-27 | — | — | US | disclosed |
| US-4084053-A | YELLOW AND ORANGE DYES, PYRIMIDINO(4',5':5,6)-1,2,4-TRIAZINO(4,3-BETA)INDAZOLES | CIBA-GEIGY CORPORATION (US) | 1978-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100127616-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE | EML4, EPB41, MLLT1 | KMT2A 2434/4885MEN1 618/4885MAPT 1792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.